We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Voluntary Recall

News List

FDA Announces Voluntary Recall of Montelukast americanpharmaceuticalreview
September 05, 2018
The U.S. Food and Drug Administration (FDA) is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Piscataway, N.J.
Camber Pharmaceuticals Issues Voluntary Recall of Montelukast Tablets newsnow
September 04, 2018
The FDA is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets lot number MON17384, expiration 12/31/2019 by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast